118 related articles for article (PubMed ID: 35997145)
21. Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study.
Polster AV; Palsson OS; Törnblom H; Öhman L; Sperber AD; Whitehead WE; Simrén M
Neurogastroenterol Motil; 2019 Jan; 31(1):e13483. PubMed ID: 30393924
[TBL] [Abstract][Full Text] [Related]
22. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
[TBL] [Abstract][Full Text] [Related]
23. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
[TBL] [Abstract][Full Text] [Related]
25. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study.
Ghoshal UC; Ghoshal U; Rahman MM; Mathur A; Rai S; Akhter M; Mostafa T; Islam MS; Haque SA; Pandey A; Kibria MG; Ahmed F
J Gastroenterol Hepatol; 2022 Mar; 37(3):489-498. PubMed ID: 34672022
[TBL] [Abstract][Full Text] [Related]
26. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
Goodoory VC; Houghton LA; Yiannakou Y; Black CJ; Ford AC
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of nausea in children with pain-associated functional gastrointestinal disorders: are Rome criteria applicable?
Kovacic K; Williams S; Li BU; Chelimsky G; Miranda A
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):311-5. PubMed ID: 23591912
[TBL] [Abstract][Full Text] [Related]
28. Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study.
Barberio B; Yiannakou Y; Houghton LA; Black CJ; Savarino EV; Ford AC
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e89-e101. PubMed ID: 33839276
[TBL] [Abstract][Full Text] [Related]
29. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
30. Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome.
Reding KW; Cain KC; Jarrett ME; Eugenio MD; Heitkemper MM
Am J Gastroenterol; 2013 Feb; 108(2):270-6. PubMed ID: 23295280
[TBL] [Abstract][Full Text] [Related]
31. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
32. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.
Wong RK; Palsson OS; Turner MJ; Levy RL; Feld AD; von Korff M; Whitehead WE
Am J Gastroenterol; 2010 Oct; 105(10):2228-34. PubMed ID: 20502449
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
[TBL] [Abstract][Full Text] [Related]
34. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
[TBL] [Abstract][Full Text] [Related]
35. Can irritable bowel syndrome be detected by ultrasound?
Okawa Y
Drug Discov Ther; 2020 Nov; 14(5):213-217. PubMed ID: 33116042
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal symptoms related to the irritable bowel syndrome - a longitudinal population-based register study.
Heinsvig Poulsen C; Falgaard Eplov L; Hjorthøj C; Eliasen M; Frost Ebstrup J; Skovbjerg S; Schröder A; Jørgensen T
Scand J Gastroenterol; 2016; 51(4):420-6. PubMed ID: 26635123
[TBL] [Abstract][Full Text] [Related]
37. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
[TBL] [Abstract][Full Text] [Related]
38. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
39. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
[TBL] [Abstract][Full Text] [Related]
40. Rome III survey of irritable bowel syndrome among ethnic Malays.
Lee YY; Waid A; Tan HJ; Chua AS; Whitehead WE
World J Gastroenterol; 2012 Nov; 18(44):6475-80; discussion p. 6479. PubMed ID: 23197894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
